← Back to Knowledge Base

Primary topic: SLC46A1 gene methylation and B-vitamin use

SLC46A1 Gene and Metabolism: What It Can Mean in a Pathway Report

SLC46A1 is tracked because it connects to homocysteine handling, folate use, and one-carbon metabolism. The current evidence index links this gene to Methylation with 4 SNPs and 4 curated claims.

What is the SLC46A1 gene?

Proton-coupled folate transporter supporting intestinal folate absorption and folate delivery into one-carbon metabolism.

How SLC46A1 affects metabolism

When SLC46A1-related function is shifted, the practical effect is interpreted through homocysteine handling, folate use, and one-carbon metabolism. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.

What happens when SLC46A1 is altered

Altered SLC46A1 signal should be treated as a DNA-based tendency, not a diagnosis. 4 claims currently pass the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.

Curated SNP evidence for SLC46A1

These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.

Evidence-backed report connection

SLC46A1 currently has 4 curated SNPs, 4 claim-level scores, and 4 claims eligible for pathway scoring.

Open the sample report
rs281875209SLC46A1 c.1012G>C / Gly338Arg1 claims · 3 study rows

transport activity · GG or compound-heterozygous SLC46A1 deficiency context

Proton-coupled folate transporter activity tendency

Strong

rs281875209 G (forward-genomic; SLC46A1 c.1012G>C / p.Gly338Arg transcript context) is associated with lower proton-coupled folate transporter activity tendency and impaired folate absorption in recessive or compound-heterozygous hereditary folate-malabsorption contexts.

SLC46A1 rs281875209 G is staged as the forward-genomic recessive hereditary folate-malabsorption allele affecting PCFT folate transport and methylation folate supply.

Likely effectLower transport signal
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
rs80338769SLC46A1 c.194del / Gly65fs1 claims · 2 study rows

transport activity · biallelic or compound-heterozygous SLC46A1 c.194del context

PCFT folate transport activity tendency

Strong

rs80338769 / SLC46A1 c.194del frameshift is associated with lower PCFT folate transport activity tendency in recessive or compound-heterozygous deficiency contexts.

SLC46A1 rs80338769 is staged as a recessive hereditary folate-malabsorption frameshift allele affecting proton-coupled folate transport.

Likely effectLower transport signal
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
rs80338770SLC46A1 c.337C>T / Arg113Cys1 claims · 2 study rows

transport activity · AA or compound-heterozygous SLC46A1 deficiency context

PCFT folate transport activity tendency

Strong

rs80338770 A on the genomic plus strand / SLC46A1 c.337C>T / p.Arg113Cys is associated with lower proton-coupled folate transporter activity in recessive or compound-heterozygous hereditary folate malabsorption contexts.

SLC46A1 rs80338770 A is staged as a pathogenic PCFT folate transport allele relevant to methylation support.

Likely effectLower transport signal
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
rs80338775SLC46A1 c.1082-1G>A1 claims · 2 study rows

transport activity · TT or compound-heterozygous SLC46A1 deficiency context

PCFT folate transport activity tendency

Strong

rs80338775 T on the genomic plus strand / SLC46A1 c.1082-1G>A is associated with lower PCFT folate transport activity tendency in recessive or compound-heterozygous deficiency contexts.

SLC46A1 rs80338775 T is staged as a recessive hereditary folate-malabsorption allele affecting proton-coupled folate transport.

Likely effectLower transport signal
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence

Common symptoms people report

  • fatigue or brain fog under workload
  • higher concern around homocysteine balance
  • unpredictable response to B-vitamin intake

Biomarkers to validate

Homocysteine

Checks whether methylation support is actually under strain.

Folate and B12

Helps separate folate-cycle pressure from broader B-vitamin status.

CBC and MCV

Adds context for red-blood-cell and B-vitamin patterns.

Where DNA analysis helps

DNA helps decide whether SLC46A1 deserves attention inside the broader Methylation pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.

Example interpretation

SLC46A1 may add context to homocysteine handling, folate use, and one-carbon metabolism, especially when its SNP evidence lines up with other genes in the same pathway.

Suggested validation: Homocysteine.

What to do next

  • Review the Methylation pathway result before interpreting SLC46A1 on its own.
  • Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
  • Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.

Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.

Get My DNA Report

Related pages